Activation of mTORC1/mTORC2 signaling in pediatric low-grade glioma and pilocytic astrocytoma reveals mTOR as a therapeutic target
Marianne Hütt-Cabezas(NYU Langone Health), Fausto J. Rodríguez(University Hospital of Zurich)
Cited by 80
Related Papers
Alternative lengthening of telomeres, ATRX loss and H3‐K27M mutations in histologically defined pilocytic astrocytoma with anaplasia
|Brain Pathology|2018|72
MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma
|Scientific Reports|2018|46
Differential gene methylation and expression of HOX transcription factor family in orbitofacial neurofibroma
|Acta Neuropathologica Communications|2020|10
Therapeutic vulnerability to ATR inhibition in concurrent <i>NF1</i> and <i>ATRX-</i> deficient high-grade solid tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3